Levonorgestrel And Ethinyl Estradiol Kit
Product Images NDC 68180-843

9 FDA label images from Lupin Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Levonorgestrel And Ethinyl Estradiol (NDC 68180-843). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

84404388 80d0 4f77 Bd4c A221ec51c618 01

84404388 80d0 4f77 Bd4c A221ec51c618 01
Illustrative chart for Levonorgestrel and Ethinyl Estradiol Tablets USP 0.15 mg/0.03 mg showing a daily dosage schedule across 13 weeks. The chart is organized by days of the week (Sunday to Saturday) with arrows indicating the sequence to follow. Each week has a row with empty circles representing daily doses. The chart also reminds to perform monthly self breast exams and includes storage instructions at 25°C with permitted excursions.*
FDA Label Image

84404388 80d0 4f77 Bd4c A221ec51c618 02

84404388 80d0 4f77 Bd4c A221ec51c618 02
A forest plot chart comparing 'Ever COC vs. Never COC Use' and 'Current COC use vs. Never-Use' from various women's health studies. The horizontal axis represents effect estimates ranging from -1.50 to 2.00. The chart shows odds ratios (OR), relative risks (RR), and hazard ratios (HR) with confidence intervals for each study on the right side. Data points with horizontal confidence intervals are plotted against a vertical line at 1.00, representing the null effect.*
FDA Label Image

84404388 80d0 4f77 Bd4c A221ec51c618 03

84404388 80d0 4f77 Bd4c A221ec51c618 03
Chemical structure of Levonorgestrel showing its molecular formula C21H28O2 and molecular weight 312.4. The diagram depicts the steroid framework characteristic of this active ingredient.*
FDA Label Image

84404388 80d0 4f77 Bd4c A221ec51c618 04

84404388 80d0 4f77 Bd4c A221ec51c618 04
Chemical structure of Ethinyl Estradiol showing its molecular formula C20H24O2 and molecular weight 296.4, a key active ingredient in Levonorgestrel and Ethinyl Estradiol products by Lupin Pharmaceuticals.*
FDA Label Image

84404388 80d0 4f77 Bd4c A221ec51c618 05

84404388 80d0 4f77 Bd4c A221ec51c618 05
A vertical efficacy chart comparing various birth control methods by pregnancies per 100 women in one year. It ranges from fewer pregnancies to more pregnancies, listing implants, injections, intrauterine devices, and sterilization as most effective; birth control pills, skin patch, and vaginal ring as moderately effective; condoms and diaphragm as less effective; no sex during fertile days, spermicide, and withdrawal with higher pregnancy rates; and no birth control as least effective.*
FDA Label Image

84404388 80d0 4f77 Bd4c A221ec51c618 06

84404388 80d0 4f77 Bd4c A221ec51c618 06
The image shows a dosing schedule for Levonorgestrel and Ethinyl Estradiol Tablets USP, 0.15 mg/0.03 mg, arranged in a 13-week calendar format. Each week is presented with days Sunday through Saturday, with arrows indicating the order to take the tablets. It includes a reminder for monthly self-breast exams and storage instructions at 25°C (77°F) with allowable excursions between 15° to 30°C (59° to 86°F). The Lupin logo is displayed.*
FDA Label Image

84404388 80d0 4f77 Bd4c A221ec51c618 07

84404388 80d0 4f77 Bd4c A221ec51c618 07
Packaging label for Levonorgestrel and Ethinyl Estradiol Tablets USP 0.15 mg/0.03 mg Kit by Lupin Pharmaceuticals, Inc. The label includes a detailed layout of tablets arranged by weeks and days for a multi-week supply. It includes storage instructions, warnings about child resistance, and distribution and manufacturing information indicating Lupin Limited, India.*
FDA Label Image

84404388 80d0 4f77 Bd4c A221ec51c618 08

84404388 80d0 4f77 Bd4c A221ec51c618 08
Label for Levonorgestrel and Ethinyl Estradiol Tablets USP 0.15 mg/0.03 mg by Lupin Pharmaceuticals, Inc. The label indicates an extended-cycle kit containing 91 tablets. It includes prescription status (Rx only), storage instructions, and a warning that the product does not protect against HIV or other sexually transmitted diseases. The Lupin logo is present, along with NDC and barcode details.*
FDA Label Image

84404388 80d0 4f77 Bd4c A221ec51c618 09

84404388 80d0 4f77 Bd4c A221ec51c618 09
Packaging label for Levonorgestrel and Ethinyl Estradiol Tablets USP 0.15 mg/0.03 mg, a prescription drug kit by Lupin Pharmaceuticals, Inc. The box includes 3 extended-cycle wallets of 91 tablets each. The label contains dosage information, NDC 68180-843-13, and storage instructions along with a warning about non-protection against HIV/AIDS and other sexually transmitted diseases.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.